Brentuximab vedotin, Cyclophosphamide, Doxorubicin, and Prednisone
About
Membership operator: AND
Therapies: 4
Therapies
Brentuximab vedotin (tx:ncit:C66944)
Cyclophosphamide (tx:ncit:C405)
Doxorubicin (tx:ncit:C456)
Prednisone (tx:ncit:C770)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy group.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (2) | CD30 + | Anaplastic Large Cell Lymphoma | Brentuximab vedotin, Cyclophosphamide, Doxorubicin, Prednisone |